✦ LIBER ✦

Feasibility trial of adjuvant chemotherapy with paclitaxel and carboplatin after surgical resection in Japanese patients with non-small cell lung cancer: report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0501

✍ Scribed by Riichiroh Maruyama; Ichiro Yoshino; Shoji Tokunaga; Morio Ohta; Masato Kato; Hiroyuki Yoshimine; Koji Yamazaki; Yoichi Nakanishi; Yukito Ichinose

Book ID: 107497455
Publisher: Springer Japan
Year: 2008
Tongue: Japanese
Weight: 217 KB
Volume: 56
Category: Article
ISSN: 1863-6705
DOI: 10.1007/s11748-007-0188-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A feasibility trial of postoperative adj

A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901

✍ Maruyama, Riichiroh; Ebi, Noriyuki; Kishimoto, Junji; Kato, Masato; Yano, Tokuji 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 227 KB

The feasibility of adjuvant carboplatin

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected locally advanced non-small cell lung cancer

✍ Sun, Hai-bo; Wang, Si-yu; Ou, Wei; Zhang, Bin-bin; Yang, Hua; Fang, Qin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A multicenter phase II study of carbopla

A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial

✍ Masao Ichiki; Masayuki Kawasaki; Koichi Takayama; Kiyoshi Ninomiya; Mutsuo Kuba; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 211 KB

Phase II study of carboplatin and gemcit

Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial

✍ Noriyasu Usami; Kohei Yokoi; Yoshinori Hasegawa; Hiroyuki Taniguchi; Joe Shindo; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 158 KB

771 Paclitaxel and carboplatin as adjuva

771 Paclitaxel and carboplatin as adjuvant treatment in high-risk patients with operable non-small cell lung cancer (NSCLC): A feasibility study conducted by the hellenic cooperative oncology group (HeCOG)

✍ H. Timotheadou; Ch. Christodoulou; Ch. Papakonstantinou; S. Papadopoulos; J. Skr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II trial of postoperative adjuvant

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)

✍ Ryosuke Tsuchiya; Kenji Suzuki; Yukito Ichinose; Yoh Watanabe; Tsutomu Yasumitsu 📂 Article 📅 2005 🏛 CTSNet 🌐 English ⚖ 202 KB